Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects

Am Rev Respir Dis. 1991 May;143(5 Pt 1):1025-9. doi: 10.1164/ajrccm/143.5_Pt_1.1025.


Urinary leukotriene E4 (LTE4) concentrations have been measured in six asthmatic patients with aspirin sensitivity and in five asthmatic subjects tolerant of aspirin, before and after provocation with aspirin or placebo. Aspirin-sensitive subjects showed an average 21% fall in FEV1 after aspirin challenge whereas control individuals had a 2% fall in FEV1 after ingestion of 100 mg aspirin. The resting urinary LTE4 concentrations in asthmatic subjects sensitive to aspirin were 243 pg/mg creatinine (range 50 to 1,041), and these were on average sixfold greater than those in control asthmatic subjects. Further, there was a mean fourfold increase in urinary LTE4 levels at 3 to 6 h after aspirin, but not placebo, challenge in aspirin-sensitive asthmatic subjects that was not seen in the control asthmatic individuals. Leukotriene release may play a central role in the mechanisms of asthmatic attacks produced by aspirin ingestion.

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aspirin / adverse effects*
  • Asthma / chemically induced*
  • Asthma / urine
  • Bronchial Provocation Tests
  • Bronchial Spasm / chemically induced
  • Double-Blind Method
  • Female
  • Forced Expiratory Volume
  • Humans
  • Leukotriene E4
  • Male
  • Methacholine Chloride
  • Middle Aged
  • SRS-A / analogs & derivatives*
  • SRS-A / urine


  • SRS-A
  • Methacholine Chloride
  • Leukotriene E4
  • Aspirin